关节痛注射市场策略、顶级参与者、增长机会、2028 年分析和预测

  • Report Code : TIPRE00003536
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 162
Buy Now

[研究报告] 关节痛注射市场预计将从 2020 年的 36.6745 亿美元增至 2028 年的 69.9688 亿美元;预计 2021-2028 年期间的复合年增长率为 8.5%。

关节疼痛注射可以更快地缓解剧烈疼痛并减少关节炎症。市场上有几种注射剂,包括皮质类固醇注射剂、透明质酸 (HA) 注射剂、富血小板血浆 (PRP) 注射剂和胎盘组织基质 (PTM) 注射剂。关节疼痛注射市场的增长归因于肌肉骨骼疾病患病率高和运动损伤数量增加等因素。然而,关节修复疗法的高成本阻碍了市场的增长

市场洞察


肌肉骨骼疾病患病率高

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

关节痛注射市场:

关节痛注射市场
  • Joint Pain Injection Market
    复合年增长率(2020 - 2028 年)
    8.5%
  • 2020 年市场规模
    36.7 亿美元
  • 2028 年市场规模
    70 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 中外制药株式会社
  • Bioventus 公司
  • Fidia Pharma 美国公司
  • Flexion Therapeutics 公司
  • 生化学株式会社
  • 费林公司
  • 赛诺菲
  • Anika Therapeutics, Inc.
  • 梯瓦制药

区域概况

Joint Pain Injection Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Joint Pain Injection Market药品
  • 透明质酸
  • 皮质类固醇
  • 其他的
Joint Pain Injection Market关节类型
  • 膝盖
  • 足部和踝部
  • 肩部和肘部
  • 时髦的
  • 其他的
Joint Pain Injection Market分销渠道
  • 零售药店
  • 医院 药店
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

肌肉骨骼疾病是影响颈部、肩部、手腕、背部、臀部、腿部、膝盖和足部的肌肉、骨骼和关节的疾病。这些疾病包括肌腱炎、腕管综合征、骨关节炎、类风湿性关节炎 (RA)、纤维肌痛和骨折。根据世界卫生组织 (WHO) 2018 年更新的情况说明书,肌肉骨骼疾病是全球第二大致残因素。据此,随着全球老龄化人口的增加和非传染性疾病 (NCD) 风险因素的患病率上升,肌肉骨骼疾病的患病率和影响预计会增加。根据 2016 年美国骨科医师学会年会的数据,在美国,每 2 个成年人中约有 1 个患有肌肉骨骼疾病。此外,根据美国疾病控制与预防中心 (CDC) 的数据,关节炎引起的剧烈疼痛每年影响着美国数百万人。大约四分之一的关节炎患者,即约 5400 万患者中的约 1500 万人,会经历与关节炎相关的严重关节疼痛。

此外,骨关节炎 (OA) 是美国最常见的关节疾病之一,由骨骼之间的关节软骨破裂引起。它也被称为退行性关节病或“磨损性”关节炎。根据美国疾病控制和预防中心 (CDC) 的数据,美国有超过 3250 万成年人患有骨关节炎。同样,根据国家医疗服务体系 (NHS) 的数据,英国有超过 1000 万人患有关节炎或其他类似的关节疾病。根据保柏健康保险的数据,骨关节炎是英国最常见的关节炎形式,影响到英国约三分之一的 45 岁或以上人群,即约 875 万人。因此,不同国家肌肉骨骼疾病的患病率如此之高,导致针对该疾病的治疗程序数量不断增加,从而推动了关节痛注射市场的增长。

基于药物的见解

关节止痛注射市场按药物分为透明质酸、皮质类固醇等。皮质类固醇在 2020 年占据了最大的市场份额,预计在预测期内将实现最高的复合年增长率。

基于联合类型的洞察

根据关节类型,关节疼痛注射市场细分为膝盖、足踝、肩肘、臀部和其他应用。膝盖部位在 2020 年占据最大市场份额,预计在预测期内将实现市场最高复合年增长率。

关节痛注射市场报告范围

报告属性细节
2020 年市场规模36.7亿美元
2028 年市场规模70亿美元
全球复合年增长率(2020 - 2028)8.5%
历史数据2018-2019
预测期2021-2028
涵盖的领域按药物分类
  • 透明质酸
  • 皮质类固醇
  • 其他的
按关节类型
  • 膝盖
  • 足部和踝部
  • 肩部和肘部
  • 时髦的
  • 其他的
按分销渠道
  • 零售药店
  • 医院 药店
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 中外制药株式会社
  • Bioventus 公司
  • Fidia Pharma 美国公司
  • Flexion Therapeutics 公司
  • 生化学株式会社
  • 费林公司
  • 赛诺菲
  • Anika Therapeutics, Inc.
  • 梯瓦制药
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

基于分销渠道的洞察

根据分销渠道,关节痛注射市场分为零售药店、医院药店和其他。伤口护理部分在 2020 年占据了最大的市场份额,而骨移植部分预计在预测期内在市场上的复合年增长率最高。

产品发布和审批是企业扩大全球业务和产品组合的常用策略。此外,关节止痛注射剂市场参与者专注于合作策略来扩大客户群,这反过来又使他们能够在全球范围内维护自己的品牌。

关节痛注射市场 – 按药物分类

  • 透明质酸
  • 皮质类固醇
  • 其他的

关节痛注射市场 – 按关节类型

  • 膝盖
  • 足部和踝部
  • 肩部和肘部
  • 时髦的
  • 其他的

关节痛注射市场 – 按分销渠道

  • 零售药店
  • 医院 药店
  • 其他的

关节痛注射市场——按地区划分

  • 北美

    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲

    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)

    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲 (MEA)

    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲(SCAM)

    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

公司简介

  • 中外制药株式会社            
  • Bioventus 公司       
  • Fidia Pharma 美国公司      
  • Flexion Therapeutics 公司           
  • 生化学株式会社         
  • 费林公司           
  • 赛诺菲         
  • Anika Therapeutics, Inc.             
  • 梯瓦制药        
  • OrthogenRx 公司
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the joint pain injection market?

The joint pain injection market majorly consists of the players such as Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika Therapeutics, Inc., and OrthogenRx among others.

What are the driving factors for the joint pain injection market across the globe?

The global joint pain injection market growth is mainly attributed to factors such the high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, the high costs of joint repair therapies hinder the market growth.

What are joint pain injections?

Joint pain injections are medicinal fluids inserted in the patient’s body to get faster relief from severe pain. The joint pain injections are used to reduce inflammation in the joints. There are several types of injections available in the market which are corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections and placental tissue matrix (PTM) injections.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Joint Pain Injection Market

  1. Chugai Pharmaceutical Co., Ltd.              
  2. Bioventus Inc.                
  3. Fidia Pharma USA Inc.                
  4. Flexion Therapeutics, Inc.          
  5. SEIKAGAKU CORPORATION       
  6. Ferring B.V.     
  7. Sanofi              
  8. Anika Therapeutics, Inc.             
  9. Teva Pharmaceutical                  
  10. OrthogenRx, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.